Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve

Figure 2 Wound bed Type I and IIa. A: Burn before Nexobrid^® treatment; B: Burn after Nexobrid^® treatment with two different wound bed. Type I, with abundance of small diameter pin-point bleeders (uniform shades of red to pink, superficial partial thickness burn). Type IIa, with a sparse pattern of larger diameter bleeders (irregular shades of pink to white colour), not depressed either in relation to the surrounding healthy skin or the own bed surface skin bed (mid/deep partial thickness burn); C: Outcome 38 d post-burn.